Active surveillance is the preferred approach to clinical stage I testicular cancer
J Clin Oncol
.
2013 Oct 1;31(28):3490-3.
doi: 10.1200/JCO.2012.47.6010.
Epub 2013 Sep 3.
Authors
Craig R Nichols
1
,
Bruce Roth
,
Peter Albers
,
Lawrence H Einhorn
,
Richard Foster
,
Siamak Daneshmand
,
Michael Jewett
,
Padraig Warde
,
Christopher J Sweeney
,
Clair Beard
,
Tom Powles
,
Scott Tyldesley
,
Alan So
,
Christopher Porter
,
Semra Olgac
,
Karim Fizazi
,
Brandon Hayes-Lattin
,
Peter Grimison
,
Guy Toner
,
Richard Cathomas
,
Carsten Bokemeyer
,
Christian Kollmannsberger
Affiliation
1
Virginia Mason Medical Center, Seattle, WA.
PMID:
24002502
DOI:
10.1200/JCO.2012.47.6010
No abstract available
MeSH terms
Humans
Male
Neoplasm Staging
Population Surveillance*
Practice Patterns, Physicians'
Testicular Neoplasms / pathology*
Testicular Neoplasms / therapy*
Watchful Waiting*